Clinical Trial Update: Monitoring to the Evolution of Motor Function in SMA Type II Adults Patients Treated With SPINRAZA® [NA]

View source ↗

Summary

This clinical trial update notes ongoing monitoring of motor function in adults with Spinal Muscular Atrophy Type II who are treated with Spinraza (nusinersen).…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Muscular Atrophy

Drugs mentioned

• Spinraza (nusinersen)

Snippet

Sponsor: Centre Hospitalier Universitaire de Nice | Conditions: Spinal Muscular Atrophy | NA | Status: ACTIVE_NOT_RECRUITING